NTLA
Intellia Therapeutics, Inc.
Halal Rating :
See Details
Last Price
$32.39
Last updated:
Market Cap
$3.33b
7D Change
-6.97%
1 Year Change
-43.67%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 2, 2023
Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $16.39m | $145.93m | $12.65m | - | 77.18% | 0.00% |
| March 31, 2023 | $20.34m | $124.56m | $11.98m | $8.83m | 58.90% | 7.09% |
| Dec. 31, 2022 | $22.0m | $123.66m | $5.35m | $5.35m | 24.34% | 4.33% |
Company Impact
Help us evaluate Intellia Therapeutics, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.